Last reviewed · How we verify
iron sucrose injection USP — Competitive Intelligence Brief
phase 3
Iron replacement agent
Iron (Fe3+) delivery; transferrin receptor-mediated uptake
Hematology
Small molecule
Live · refreshed every 30 min
Target snapshot
iron sucrose injection USP (iron sucrose injection USP) — American Regent, Inc.. Iron sucrose delivers iron directly into the bloodstream as a stable complex to replenish iron stores and support hemoglobin synthesis in patients with iron deficiency.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| iron sucrose injection USP TARGET | iron sucrose injection USP | American Regent, Inc. | phase 3 | Iron replacement agent | Iron (Fe3+) delivery; transferrin receptor-mediated uptake | |
| i.v. iron sucrose | i.v. iron sucrose | J. Uriach and Company | marketed | Iron replacement agent | ||
| Venofer® | Venofer® | Azad Pharma AG | marketed | Iron replacement agent | ||
| High-dose ferric derisomaltose | High-dose ferric derisomaltose | China-Japan Friendship Hospital | marketed | Iron replacement agent | ||
| Sodium ferric gluconate | Sodium ferric gluconate | University of North Carolina, Chapel Hill | marketed | Iron replacement agent | Iron (Fe3+) delivery system | |
| Iron Carboxymaltose | Iron Carboxymaltose | Albina Nowak, MD | marketed | Intravenous iron replacement agent | Iron(III) ion; transferrin and ferritin (iron-binding proteins) | |
| Ferric Carboxymaltose Injection | Ferric Carboxymaltose Injection | Sichuan Huiyu Pharmaceutical Co., Ltd | marketed | Iron replacement agent | Iron metabolism pathway; transferrin receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Iron replacement agent class)
- University of Maryland, Baltimore · 2 drugs in this class
- Ain Shams University · 1 drug in this class
- American Regent, Inc. · 1 drug in this class
- Azad Pharma AG · 1 drug in this class
- CN NGANOU-GNINDJIO, MD, MSc · 1 drug in this class
- China-Japan Friendship Hospital · 1 drug in this class
- Hallym University Medical Center · 1 drug in this class
- J. Uriach and Company · 1 drug in this class
- JW Pharmaceutical · 1 drug in this class
- Prince of Wales Hospital, Shatin, Hong Kong · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- iron sucrose injection USP CI watch — RSS
- iron sucrose injection USP CI watch — Atom
- iron sucrose injection USP CI watch — JSON
- iron sucrose injection USP alone — RSS
- Whole Iron replacement agent class — RSS
Cite this brief
Drug Landscape (2026). iron sucrose injection USP — Competitive Intelligence Brief. https://druglandscape.com/ci/iron-sucrose-injection-usp. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab